Cross Atlantic Commodities Inc (CXAC): 3/02/09 Quote from Bravo: "I want to put

OTC BB | Miscellaneous | Cross Atlantic Commodities Inc (CXAC)

Public Reply | Private Reply | Keep | Last Read

Posted by: cj56727	Date: Saturday, November 07, 2009 7:03:06 PM
In reply to: cj56727 who wrote msg# 40899	Post # of 47477

3/02/09 Quote from Bravo: "I want to put an end to the rumors about a reverse split." "There wasn't a need to reverse split our stock in the first quarter nor will there be a need in the second quarter. We are moving along just fine and don't see the need to get involved with a reorganization of the company's stock. A reverse is not going to happen in Q2. Bravo concluded by stating, "We will continue to fight for a better stock price but at this very moment our sole focus is revenue. As I have stated before, the revenue will drive our stock's price. I am not overly concerned with the daily stock activity; currently we believe traders are taking advantage of our volatility. As soon as we are fully transparent the stock should take care of itself.
http://www.globenewswire.com/newsroom/news.html?d=160589

3/10/09 CXAC announces it has signed a Letter of Intent to acquire T-3 Media Inc. Bravo stated, "We are extremely thrilled to be announcing today's news. Management has worked tirelessly to bring value back to CXAC shareholders and today's news is without a doubt the biggest news we have had to report in a very long time.” With T-3 as a wholly owned subsidiary of CXAC Jorge Bravo will remain CEO of CXAC and Stephan Todd Smith will become President of T-3 Media, Inc. and shall become a Director of CXAC.

3/16/09 CXAC Finalizes T-3 Media Inc Merger. Under the term of the merger, T-3 Media is now a wholly owned subsidiary of CXAC. T-3 will receive 10% of the outstanding shares of CXAC in restricted stock; these shares will be restricted for two years, with an earn-out when successful milestones are reached. Todd Smith will head T-3 as president; and Jorge Bravo remains C.E.O. of Cross Atlantic Commodities. Kim Marks will be the CPA; he will prepare all financial information on both companies. Once financial statements and disclosures are completed, Jorge Bravo will upload the documents to pinksheets.com.
http://www.globenewswire.com/newsroom/news.html?d=161405

5/4/09 CXAC Updates Shareholders on T3 Media Agreement. T3 to remain a private company, CXAC will serve as operations mechanism for T3’s product lines. Says T3 President Todd Smith, "It was not the banking or reverse merger capabilities that T3 sought from CXAC. It was the expertise of Jorge Bravo, Jr and company at CXAC that T3 requires for successful product launch." T3 will continue to research, develop and acquire quality lifestyle enhancement products for men and women who seek to achieve fulfilling personal lives. CXAC and their expert management team will provide the foundation for sales, marketing and logistics for T3.
http://www.globenewswire.com/newsroom/news.html?d=164511

7/22/09 Cross Atlantic Commodities, Inc. Launches Affiliate Marketing Campaign with Clickbooth.com for Its ReJuv by Caci Line. Bravo emphasized the tremendous marketing reach of the program, as Clickbooth has over 25,000 active publishers. "We have been working with Clickbooth for the past two months. They have reviewed our ReJuv by Caci Anti-Aging Essentials line, and feel we have one of the stronger products in our market," said Bravo. As a performance based company, Clickbooth works to ensure the success of the advertisers and publishers that it accepts into its network.
http://www.globenewswire.com/newsroom/news.html?d=169525

9/02/09 CXAC launches national Internet marketing programs. “Combining the efforts of two leaders in Internet marketing, ClickBooth and Online Performance Marketing, LP, with the necessary resources and the proven marketing program, RE-JUV by Caci. will be a successful formula to drive new customer acquisition cost effectively,” said Bravo. Online Performance Marketing will promote our product on major search engines such as, Google®, Yahoo® and Bing®, using their latest technology to drive internet shopping traffic through optimized clicks, phone calls and conversions to generate a marked increase in our product sales. The company expects to expand both Brand recognition and continuity of sales. The Company estimates that it will add $500,000 in revenue growth by year-end 2009, and estimates the largest growth to come in years 2010 and 2011; topping $5 million in revenue growth by year-end 2010 as it adds additional brands to its line-up.

9/16/09 CXAC announces launch date of television commercials. “Our Internet presence has now increased to the point where we can comfortably augment and support a major TV blitz,” reported Bravo. “We will begin implementing a multitude of Television Commercials across several Networks as we continue with our longstanding goal of establishing a strong market presence for our skin product; RE-JUV® by CACI.” With the previously announced sales projections already set at $2 million over the next 12 months, the Company is also expecting to add new products to the line up in the very near future. Further details on these additional product launches will be immediately provided as each pending agreement finalizes over the coming days. The Company would also like to provide a market update as it pertains to their previously announced goal of increasing their transparency level on Pink Sheets. “As of today’s date, we are on target to provide Pink Sheets with a report on our current financials immediately following our auditor’s release,” CEO Bravo stated. “I look forward to providing several more details on all our branding, sales, expanding product lines and increased transparency efforts, as I begin to cultivate a strong sense of shareholder value and regular lines of communication moving forward,” ended CEO Bravo.

10/19/09 CXAC signs agreement to market Snorenz(R) with the holders of the Snorenz patent. Snorenz(R) is a nationally well known snoring product.
"We have done our homework on Snorenz(R) and are very excited about the research that the previous company has done and the size of the snoring category", states Bravo. In 2002, the Company completed a double blind study at Northwestern Hospital's Sleep Center in Atlanta, GA, under the direction of Dr. Samuel Mickelson of the Advanced Ear Nose and Throat P.C. The results of that study concluded that SNORenz(R) is an effective product to reduce the noise associated with snoring. We will begin marketing Snorenz, first through Online Marketing, Pay Per Search and Affiliate Marketing Programs. Within the next few weeks our new Snorenz website will be live. In other news: We are proud to release the revised commercial for the Re Juv by Caci Immediate Results Commercial.
*Unless otherwise noted, information for this timeline were obtained from the following:
http://si.advfn.com/p.php?pid=news&cb=1257625734&symbol=USOTC%3ACXAC&old_symbol=USOTC%3ACXAC&from_month=1&from_day=1&from_year=2001&order=desc&to_month=12&to_day=30&to_year=2011&selsrc[0]=edgar&email=Enter+Email+Here&elists=1|3|7&sec=1

Cross Atlantic Commodities Inc (CXAC) Stock Trading Info:

Public Reply | Private Reply | Keep | Last Read

Replies (3) | Next 10 | Previous | Next

Add Cross Atlantic Commodities Inc (CXAC) To Favorites

Keyboard Shortcuts

Report TOS Violation


Current Price
Change
Volume
Detailed Quote - Discussion Board

+/- to Watchlist